Project Details
Description
The UK currently has one of the worst survival rates for cancer in Western Europe, with one in every five women newly diagnosed with breast cancer dying. At present, screening mammograms do not find about 20% of breast cancers and there has been a global move towards breast MRI as a more efficient screening method.
However, current technology still requires human interpretation of the image data which can be timely and subject to human error, due to fatigue or stretched resources for example.
The INTELLISCAN project, funded by Innovate UK, is using advanced image processing and deep machine learning to deliver improved automated detection for breast MRI scans. The technology will utilise a Breast Image Interpretation and Transmission Model (BIITM) to interpret and transmit image data, instantly detecting anomalies and categorising them by severity. It will also flag any discrepancies through the patient’s history and expected progress.
However, current technology still requires human interpretation of the image data which can be timely and subject to human error, due to fatigue or stretched resources for example.
The INTELLISCAN project, funded by Innovate UK, is using advanced image processing and deep machine learning to deliver improved automated detection for breast MRI scans. The technology will utilise a Breast Image Interpretation and Transmission Model (BIITM) to interpret and transmit image data, instantly detecting anomalies and categorising them by severity. It will also flag any discrepancies through the patient’s history and expected progress.
| Acronym | IntelliScan |
|---|---|
| Status | Finished |
| Effective start/end date | 1/02/18 → 31/10/20 |
Funding
- Innovate UK
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.